Visby Medical stock

Visby Medical Stock


Looking to sell Visby Medical stock or options?

Contact us
Founded: 2012Funding to Date: $439M
Visit website

Visby Medical is a developer of diagnostic testing devices based on polymerase chain reaction (PCR) specifically designed for the detection of infectious diseases. The company excels in creating single-use handheld self-testing kits that yield instrument-free results. Visby Medical's range of medical services encompasses sexual health tests, respiratory health tests, and tests for other infectious diseases like COVID-19, chlamydia, gonorrhea, and trichomonas. This makes infectious disease testing as straightforward and accessible as possible for patients.

Investors Include:

Nissim Capital, Highbury Group, Hutchison Port Group, Amplify Partners, Rheinest, Lightrock, CARB-X, Ling Wong, Ping An Voyager Partners, J-Ventures, Healthcare of Ontario Pension Plan, Blue Water Life Science Advisors, Cedars-Sinai, John Doerr, E Squared Capital Management, 1809 Capital, Omron Ventures, ND Capital, Dynamic Loop Capital, Artiman Ventures, Terrapin Partners, Seraph, Pitango Venture Capital, Justin Mateen, Biomedical Advanced Research and Development Authority.

Collective Representative

Looking to sell Visby Medical Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you